top of page

Browse by category

Search

First patient treated in phase 2 obesity trial of GLY-200 polymer

First patient treated in phase 2 obesity trial of GLY-200 polymer

First patient treated in phase 2 obesity trial of GLY-200 polymer

Glyscend Therapeutics has initiated a Phase 2 clinical trial of its lead candidate, GLY-200, as a novel oral treatment for obesity....

Therapeutic polymer could provide alternative to gastric bypass

Therapeutic polymer could provide alternative to gastric bypass

Therapeutic polymer could provide alternative to gastric bypass

An orally administered therapeutic polymer, GLY-200, designed to bind to and enhance the barrier function of mucus in the...

More than half of those who stop GLP-1s restart within a year

1 day ago

Coalition of Swiss organisations publish new Guidelines on Obesity

1 day ago

Study strengthens the case for insurers and policymakers to support coverage and improve access to MBS

1 day ago

Back to Top

bottom of page